IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - ELI:IBS - PTIBS0AM0008 - Common Stock
10.55 EUR
+0.1 (+0.96%)
IBS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Hotels, Restaurants & Leisure industry. IBS has an average financial health and profitability rating. While showing a medium growth rate, IBS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
Of the past 5 years IBS 4 years were profitable.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
IBS's Return On Assets of 1.51% is in line compared to the rest of the industry. IBS outperforms 46.30% of its industry peers.
Looking at the Return On Equity, with a value of 3.42%, IBS is in line with its industry, outperforming 59.26% of the companies in the same industry.
IBS has a Return On Invested Capital (3.81%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IBS is significantly below the industry average of 11.10%.
The 3 year average ROIC (3.32%) for IBS is below the current ROIC(3.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin of 2.07%. This is comparable to the rest of the industry: IBS outperforms 44.44% of its industry peers.
In the last couple of years the Profit Margin of IBS has declined.
IBS has a Operating Margin (5.03%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IBS has declined.
IBS has a Gross Margin (50.98%) which is comparable to the rest of the industry.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBS is destroying value.
The number of shares outstanding for IBS has been reduced compared to 1 year ago.
Compared to 5 years ago, IBS has more shares outstanding
Compared to 1 year ago, IBS has a worse debt to assets ratio.
2.2 Solvency
IBS has an Altman-Z score of 2.04. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
IBS's Altman-Z score of 2.04 is fine compared to the rest of the industry. IBS outperforms 62.96% of its industry peers.
IBS has a debt to FCF ratio of 4.26. This is a neutral value as IBS would need 4.26 years to pay back of all of its debts.
IBS has a better Debt to FCF ratio (4.26) than 70.37% of its industry peers.
IBS has a Debt/Equity ratio of 0.71. This is a neutral value indicating IBS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, IBS is doing good in the industry, outperforming 70.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.04 |
ROIC/WACC0.61
WACC6.25%
2.3 Liquidity
A Current Ratio of 0.96 indicates that IBS may have some problems paying its short term obligations.
IBS's Current ratio of 0.96 is in line compared to the rest of the industry. IBS outperforms 55.56% of its industry peers.
IBS has a Quick Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
IBS has a Quick ratio of 0.87. This is comparable to the rest of the industry: IBS outperforms 51.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -30.51% in the last year.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
The Revenue has grown by 17.65% in the past year. This is quite good.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
The Earnings Per Share is expected to grow by 18.20% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.77% on average over the next years.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.58 indicates a quite expensive valuation of IBS.
Compared to the rest of the industry, the Price/Earnings ratio of IBS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 25.89, IBS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 24.72, the valuation of IBS can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 34.59. IBS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.58 | ||
| Fwd PE | 24.72 |
4.2 Price Multiples
IBS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBS is cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.18 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IBS's earnings are expected to grow with 20.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.70%, IBS is a good candidate for dividend investing.
IBS's Dividend Yield is rather good when compared to the industry average which is at 3.12. IBS pays more dividend than 100.00% of the companies in the same industry.
IBS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.7% |
5.2 History
The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBS pays out 268.99% of its income as dividend. This is not a sustainable payout ratio.
The dividend of IBS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/14/2025, 7:00:00 PM)
10.55
+0.1 (+0.96%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap437.93M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (12.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.7% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.58 | ||
| Fwd PE | 24.72 | ||
| P/S | 0.86 | ||
| P/FCF | 6.18 | ||
| P/OCF | 3.76 | ||
| P/B | 1.41 | ||
| P/tB | 2.07 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.46%
EPS(NY)0.43
Fwd EY4.04%
FCF(TTM)1.71
FCFY16.18%
OCF(TTM)2.81
OCFY26.62%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.04 |
F-Score6
WACC6.25%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y57.33%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 3 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.